Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de estudo
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Bioelectromagnetics ; 43(4): 218-224, 2022 May.
Artigo em Inglês | MEDLINE | ID: mdl-35476263

RESUMO

Radiofrequency radiation (RFR) was classified as a "possible" human carcinogen in 2011, which caused great public concern. A carcinogenicity study by the National Toxicology Program (NTP) found Code Division Multiple Access-and Global System for Mobile Communications-modulated mobile phone RFR to be carcinogenic to the brain and heart of male rats. As part of an investigation of mobile phone carcinogenesis, and to verify the NTP study results, a 5-year collaborative animal project was started in Korea and Japan in 2019. An international animal study of this type has two prerequisites: use of the same study protocol and the same RF-exposure system. This article discusses our experience in the design of this global study on radiofrequency electromagnetic fields (RF-EMFs).© 2022 The Authors. Bioelectromagnetics published by Wiley Periodicals LLC on behalf of Bioelectromagnetics Society.


Assuntos
Telefone Celular , Ondas de Rádio , Animais , Encéfalo , Carcinogênese , Campos Eletromagnéticos , Masculino , Ratos
2.
Cancer Lett ; 246(1-2): 41-6, 2007 Feb 08.
Artigo em Inglês | MEDLINE | ID: mdl-16530328

RESUMO

We investigated the effects of bovine LF (bLF) on different phases of NNK-induced lung tumorigenesis in A/J mice. Mice were orally administered 0.02, 0.2 and 2% bLF during the initiation phase, and 2% bLF during the whole tumorigenesis phase or post-initiation phase. Administered bLF during the post-initiation phase showed significant reduction of macroscopical lung nodules, and immunohistochemically decreased expression levels of cell proliferation marker and increased expression levels of apoptosis marker in lung proliferative lesions. bLF might inhibit NNK-induced mouse lung tumorigenesis, only when given limited to the post-initiation phase, through modification of cell proliferation and/or apoptosis.


Assuntos
Suplementos Nutricionais , Lactoferrina/uso terapêutico , Neoplasias Pulmonares/prevenção & controle , Adenoma/induzido quimicamente , Adenoma/metabolismo , Adenoma/prevenção & controle , Animais , Peso Corporal/efeitos dos fármacos , Caspase 3/análise , Bovinos , Feminino , Hiperplasia/induzido quimicamente , Hiperplasia/metabolismo , Hiperplasia/prevenção & controle , Lactoferrina/administração & dosagem , Pulmão/efeitos dos fármacos , Pulmão/metabolismo , Pulmão/patologia , Neoplasias Pulmonares/induzido quimicamente , Neoplasias Pulmonares/metabolismo , Camundongos , Camundongos Endogâmicos A , Nitrosaminas , Tamanho do Órgão/efeitos dos fármacos , Antígeno Nuclear de Célula em Proliferação/análise
3.
Cancer Lett ; 222(2): 145-51, 2005 May 26.
Artigo em Inglês | MEDLINE | ID: mdl-15863263

RESUMO

Arctiin, a plant lignan that can be extracted from the Arctium lappa (burdock) seeds, is a possible environmental endocrine disruptor compounds and have been shown to influence sex hormone metabolism as well as protein synthesis, steroid biosynthesis. Modifying effects of arctiin on prostate carcinogenesis in probasin/SV 40 T antigen (Tag) transgenic (TG) rats were examined. A total of 64 male TG rats, 6 weeks old, were randomly divided to three experimental groups (soybean free Oriental MF diet with 0.1, 0.02, or 0.004% arctiin) and a control group (soybean free Oriental MF diet). Animals were killed at the end of week 18. Histopathological evaluation of prostate revealed that all the rats in any group developed adenocarcinoma in dorsolateral lobe of prostate, except two rats in 0.1% arctiin treated and one rat in 0.002% arctiin treated groups without prostate adenocarcinoma development. However, there were no definite treatment-related changes with statistical significance in all parameters for prostate carcinomas measured in this experiment. These results indicated that arctiin might not exert significant modifying effect on prostate carcinogenesis in SV 40 Tag TG rats at least under the present experiment.


Assuntos
Adenoma/fisiopatologia , Furanos/farmacologia , Glucosídeos/farmacologia , Neoplasias da Próstata/fisiopatologia , Adenoma/veterinária , Administração Oral , Proteína de Ligação a Androgênios/genética , Ração Animal , Animais , Animais Geneticamente Modificados , Antígenos Transformantes de Poliomavirus/genética , Transformação Celular Neoplásica , Medicamentos de Ervas Chinesas , Masculino , Neoplasias da Próstata/veterinária , Distribuição Aleatória , Ratos , Sementes
4.
Toxicol Pathol ; 32(2): 250-7, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15200164

RESUMO

Effects of dietary administration of 1'-acetoxychavicol acetate (ACA) and the novel synthetic retinoids 4-[1-hydroxy-3-oxo-3-(5,6,7,8-tetrahydro-3-hydroxy-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl]benzoic acid (Re-80); 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carboxamido]benzoic acid (Am-580); and 6-[(3,5-di-tert-butylphenyl) carbamoyl]nicotinic acid (Am-55P) were examined using a two-stage rat carcinogenesis model. A total of 190 female SD rats was treated sequentially with 1,2-dimethylhydrazine (DMH, s.c.); 7,12-dimethylbenz(a)anthracene (DMBA, i.g.); and 2,2'-dihydroxy-di-n-propylnitrosamine (DHPN, in the drinking water) during the first three weeks (DDD-initiation), and an additional 60 rats received the vehicle alone (non-initiation). One week after the completion of the initiation period, they were divided into nine groups and administrated Re-80 (at dose levels of 1.0 or 0.4 ppm), Am-580 (20 or 4 ppm), Am-55P (20 ppm), ACA (100 ppm), all-trans-retinoic acid (10 or 2 ppm) or no supplement in the diet for 33 weeks, until survivors were euthanatized at week 37 weeks. After DDD-initiation, all-trans-retinoic acid at the high dose delayed the development of mammary tumors. The multiplicity of colon tumors in the group fed Am-55P and the incidences of nephroblastomas with ACA or Am-580 were decreased as compared with the control values, but the other chemicals had no modifying effects on tumor development in any organs. Thus, among ACA and the novel synthetic retinoids tested, only Am-55P showed a weak inhibitory effect on a neoplasm of general interest under the present experimental conditions.


Assuntos
Antineoplásicos/uso terapêutico , Benzoatos/uso terapêutico , Carcinógenos/toxicidade , Neoplasias Experimentais/prevenção & controle , Extratos Vegetais/uso terapêutico , Retinoides/uso terapêutico , Terpenos/uso terapêutico , Tetra-Hidronaftalenos/uso terapêutico , Administração Oral , Animais , Álcoois Benzílicos , Carcinógenos/administração & dosagem , Modelos Animais de Doenças , Feminino , Neoplasias Experimentais/induzido quimicamente , Neoplasias Experimentais/patologia , Ratos , Ratos Sprague-Dawley , Abastecimento de Água
5.
J Toxicol Sci ; 27(1): 57-68, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11915369

RESUMO

The potential of purple sweet potato color (PSPC) and red cabbage color (RCC), natural anthocyanin food colors, to modify colorectal carcinogenesis was investigated in male F344/DuCrj rats, initially treated with 1,2-dimethylhydrazine (DMH) and receiving 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the diet. After DMH initiation, PSPC and RCC were given at a dietary level of 5.0% in combination with 0.02% PhIP until week 36. No PSPC or RCC-treatment-related changes in clinical signs and body weight were found. Incidences and multiplicities of colorectal adenomas and carcinomas in rats initiated with DMH were clearly increased by PhIP. In contrast, lesion development was suppressed by RCC, or tended to be inhibited by PSPC administration. Furthermore, in the non-DMH initiation groups, induction of aberrant crypt foci (ACF) by PhIP was significantly decreased by RCC supplementation. The results thus demonstrate that while PhIP clearly exerts promoting effects on DMH-induced colorectal carcinogenesis, these can be reduced by 5.0% PSPC or 5.0% RCC in a diet under the present experimental conditions.


Assuntos
Adenoma/prevenção & controle , Antocianinas/uso terapêutico , Anticarcinógenos/uso terapêutico , Brassica/química , Carcinoma/prevenção & controle , Neoplasias Colorretais/prevenção & controle , Ipomoea batatas/química , Preparações de Plantas/uso terapêutico , 1,2-Dimetilidrazina/toxicidade , Adenoma/induzido quimicamente , Adenoma/patologia , Administração Oral , Animais , Antocianinas/administração & dosagem , Anticarcinógenos/administração & dosagem , Carcinógenos/toxicidade , Carcinoma/induzido quimicamente , Carcinoma/patologia , Cocarcinogênese , Colo/efeitos dos fármacos , Colo/patologia , Neoplasias Colorretais/induzido quimicamente , Neoplasias Colorretais/patologia , Dieta , Hiperplasia/induzido quimicamente , Hiperplasia/patologia , Imidazóis/toxicidade , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/patologia , Masculino , Preparações de Plantas/administração & dosagem , Lesões Pré-Cancerosas/induzido quimicamente , Lesões Pré-Cancerosas/patologia , Lesões Pré-Cancerosas/prevenção & controle , Ratos , Ratos Endogâmicos F344
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA